Navigating medtech IP protection: U.S. and European perspectives

最新情報 | 21.09.2026

In a recent episode of The Leading Difference podcast, HOFFMANN EITLE Associate Stephanie Rupp joined Ryan Phelan, Partner at U.S. intellectual property law firm Marshall Gerstein, to discuss how AI is changing medtech innovation and the IP strategies founders should consider as they develop, fund and commercialise new technologies.

The podcast explores the evolution from traditional AI model training to today’s generative AI workflows and the distinct considerations companies face when seeking patent protection in Europe and the United States. Stephanie provides insight into the European approach, including strict novelty requirements and the European Patent Office’s “technical effect” requirement for AI-related inventions. Ryan discusses the U.S. perspective, including early IP strategy, disclosures to investors and potential partners, and the use of provisional patent applications.

The episode also covers cross-border IP strategy, collaboration between European and U.S. patent counsel and the Unified Patent Court.

Listen to the full episode of The Leading Difference podcast here. 

戻る